LBA13 Phase III trial of [177Lu]Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore) - Sartor, O; Castellano, Gauna DE; Herrmann, K (Annals of Oncology, 2023)